Dietary Approach to Stop Hypertension With Sodium (Na) Reduction for Chinese Canadians
NCT ID: NCT02579746
Last Updated: 2015-10-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2014-08-31
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
mDASHNa-CC APP to Support a Healthy Diet and Hypertension Control for Chinese Canadian Seniors
NCT03988894
Lifestyle Intervention for Treating Systemic Hypertension in Primary Care Setting
NCT02492035
Dietary Approaches to Stop Hypertension (DASH)
NCT00000544
Modifying Dietary Behavior in Adolescents With Elevated Blood Pressure
NCT00585832
Korean Life-Style Modification Effects on Blood Pressure
NCT01637909
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intervention
The intervention group received usual care plus the DASHNa-CC intervention.
usual care
education booklet, encouragement of physician visit, use of public health resources if needed
DASHNa-CC
The 8-week DASHNa-CC intervention incorporated Dietary Approach to Stop Hypertension (DASH) diet, sodium reduction with the food therapy of Traditional Chinese Medicine, and included an intervention manual, two sessions of classroom instruction delivered in Mandarin, and a 20-minute telephone follow-up.
control
The control group received usual care.
usual care
education booklet, encouragement of physician visit, use of public health resources if needed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
usual care
education booklet, encouragement of physician visit, use of public health resources if needed
DASHNa-CC
The 8-week DASHNa-CC intervention incorporated Dietary Approach to Stop Hypertension (DASH) diet, sodium reduction with the food therapy of Traditional Chinese Medicine, and included an intervention manual, two sessions of classroom instruction delivered in Mandarin, and a 20-minute telephone follow-up.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* had a systolic blood pressure 140 to 159 mmHg, or a diastolic blood pressure 90 to 99 mmHg, based on pre-intervention baseline assessment;
* were able to understand (listen) and speak in Mandarin, read and write in Chinese; and
* had access to a telephone.
Exclusion Criteria
* used TCM or professional TCM counselling to decrease blood pressure during the previous three months;
* used insulin or oral hypoglycemic agents during the previous three months;
* had a history of a cardiovascular event (stroke, myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass surgery, or other arteriosclerotic cardiovascular disease related therapeutic procedure) during the previous three months;
* had a history of congestive heart failure;
* had a cancer diagnosis or treatment during the past two years;
* had special dietary requirements;
* were pregnant, breast feeding, or planned for pregnancy prior to the anticipated end of study;
* were a household member of another DASHNa-CC participant; or
* planned to leave the area prior to the anticipated end of study.
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ping Zou
RN PhD
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UofT30496
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.